🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
The purpose of this study is to determine whether ABI-009 will make advance...
Status
Terminated
Location
Ochsner Clinic Foundation
Start Date
2018-11-05
Trial ID
NCT03670030
Treatments Being Tested
Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Status
Completed
Location
Columbia University Medical Center
Start Date
2014-04-09
Trial ID
NCT02009332
Treatments Being Tested
This phase I trial studies the side effects and best dose of nanoparticle a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-08-15
Trial ID
NCT02975882
A phase 2a, open-label study to evaluate the safety, tolerability, and clin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-30
Trial ID
NCT03747328
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of nab-sirolim...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-04-01
Trial ID
NCT03660930
Treatments Being Tested
Expanded Access for an Intermediate-size Population for ABI-009 (Sirolimus ...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03817515
Treatments Being Tested
This phase Ib trial determines if samples from a patient's cancer can be te...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2020-04-01
Trial ID
NCT03878524
Treatments Being Tested
This pilot trial studies how well nanoparticle albumin-bound rapamycin work...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2016-01
Trial ID
NCT02646319
Treatments Being Tested